دورية أكاديمية
أعرض في EDS

Towards precision cancer medicine for Aboriginal and Torres Strait Islander cancer health equity.

التفاصيل البيبلوغرافية
العنوان: Towards precision cancer medicine for Aboriginal and Torres Strait Islander cancer health equity.
المؤلفون: Clark Adnyamathanha JR; Telethon Kids Institute, Adelaide, SA.; Australian National University, Canberra, ACT., Buck Kamilaroi J; Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA.; Centre for Child Health Research, University of Western Australia, Perth, WA., Richards-Satour Adnyamathanha And Barngarla A; Telethon Kids Institute, Adelaide, SA., Lyons Jaadwa L; Telethon Kids Institute, Adelaide, SA., Brown Yuin A; Telethon Kids Institute, Adelaide, SA.; National Centre for Indigenous Genomics, Australian National University, Canberra, ACT.
المصدر: The Medical journal of Australia [Med J Aust] 2024 Jul 01; Vol. 221 (1), pp. 68-73.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Australasian Medical Publishing Co Country of Publication: Australia NLM ID: 0400714 Publication Model: Print Cited Medium: Internet ISSN: 1326-5377 (Electronic) Linking ISSN: 0025729X NLM ISO Abbreviation: Med J Aust Subsets: MEDLINE
أسماء مطبوعة: Publication: : Pyrmont, NSW : Australasian Medical Publishing Co.
Original Publication: Sydney : Australasian Medical Pub. Co.
مواضيع طبية MeSH: Native Hawaiian or Other Pacific Islander* , Precision Medicine*/methods , Health Equity* , Neoplasms*/ethnology , Neoplasms*/therapy , Neoplasms*/genetics , Health Services, Indigenous*/organization & administration, Humans ; Australia ; Genomics ; Health Services Accessibility ; Healthcare Disparities/ethnology ; Australian Aboriginal and Torres Strait Islander Peoples
مستخلص: Delivering cancer control at scale for Aboriginal and Torres Strait Islander communities is a national priority that requires Aboriginal and Torres Strait Islander leadership and codesign, as well as significant involvement of the Aboriginal community-controlled health sector. The unique genomic variation observed among Aboriginal and Torres Strait Islander peoples may have implications for standard and precision medicine. Yet, Aboriginal and Torres Strait Islander peoples are absent from, or under-represented within, human reference genome resources, genomic studies, cancer studies, cancer cell lines, patient-derived xenografts and cancer clinical trials. Genomics-guided precision cancer medicine offers an opportunity to reduce cancer health disparities experienced by Aboriginal and Torres Strait Islander peoples through personalising prevention, diagnosis, treatment and long term management. Here, we describe what is required to ensure that Aboriginal and Torres Strait Islander peoples can receive the benefits of precision cancer medicine. Equity of access to care, an Aboriginal and Torres Strait Islander cancer workforce, and appropriate genome reference resources are important for safe and effective cancer medicine. Building Indigenous data sovereignty principles and Aboriginal and Torres Strait Islander governance into research is required to protect Aboriginal and Torres Strait Islander rights and collective interests. Aboriginal and Torres Strait Islander community engagement should be undertaken to develop an understanding of the unique cultural and ethical considerations for precision cancer research. Local and national genomic health research guidelines are needed to define a consensus best practice in genomics research with Aboriginal and Torres Strait Islander peoples.
(© 2024 The Author(s). Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.)
References: Australian Bureau of Statistics. Aboriginal and Torres Strait Islander life expectancy [reference period 2020–2022]. Canberra: ABS, 2023. https://www.abs.gov.au/statistics/people/aboriginal‐and‐torres‐strait‐islander‐peoples/aboriginal‐and‐torres‐strait‐islander‐life‐expectancy/latest‐release (viewed Dec 2023).
Australian Institute of Health and Welfare. Aboriginal and Torres Strait Islander Health Performance Framework — summary report 2024. Canberra: AIHW, 2024. https://www.indigenoushpf.gov.au/report‐overview/overview/summary‐report (viewed Dec 2023).
Australian Institute of Health and Welfare. Cancer in Aboriginal and Torres Strait Islander peoples of Australia: an overview [Cat. No. CAN 75]. Canberra: AIHW, 2013. https://www.aihw.gov.au/reports/cancer/cancer‐in‐indigenous‐australians‐overview/summary (viewed Dec 2023).
Australian Institute of Health and Welfare. Cancer in Australia 2021 [Cat. No. CAN 144]. Canberra: AIHW, 2021. https://www.aihw.gov.au/reports/cancer/cancer‐in‐australia‐2021 (viewed Dec 2023).
Banham D, Roder D, Keefe D, et al. Disparities in cancer stage at diagnosis and survival of Aboriginal and non‐Aboriginal South Australians. Cancer Epidemiol 2017; 48: 131‐139.
Banham D, Roder D, Keefe D, et al. Disparities in breast screening, stage at diagnosis, cancer treatment and the subsequent risk of cancer death: a retrospective, matched cohort of aboriginal and non‐aboriginal women with breast cancer. BMC Health Serv Res 2019; 19: 387.
Fitzadam S, Lin E, Creighton N, et al. Lung, breast and bowel cancer treatment for Aboriginal people in New South Wales: a population‐based cohort study. Intern Med J 2021; 51: 879‐890.
Gibberd A, Supramaniam R, Dillon A, et al. Are Aboriginal people more likely to be diagnosed with more advanced cancer? Med J Aust 2015; 202: 195‐199. https://www.mja.com.au/journal/2015/202/4/are‐aboriginal‐people‐more‐likely‐be‐diagnosed‐more‐advanced‐cancer#:~:text=While%20for%20all%20cancers%20combined,disease%20at%20diagnosis%20(Appendix).
Tervonen HE, Morrell S, Roder D, et al. Differences in cancer incidence by age at diagnosis between Aboriginal and non‐Aboriginal people for cancer types included in Australian national screening programs. Cancer Epidemiol 2019; 60: 102‐105.
Diaz A, Moore SP, Martin JH, et al. Comorbidities amongst Indigenous cancer patients: impact on treatment and survival. Int J Epidemiol 2015; 44(Suppl): i2‐i3.
Weir K, Supramaniam R, Gibberd A, et al. Comparing colorectal cancer treatment and survival for Aboriginal and non‐Aboriginal people in New South Wales. Med J Aust 2016; 204: 156. https://www.mja.com.au/journal/2016/204/4/comparing‐colorectal‐cancer‐treatment‐and‐survival‐aboriginal‐and‐non‐aboriginal.
Pule L, Buckley E, Niyonsenga T, et al. Developing a comorbidity index for comparing cancer outcomes in Aboriginal and non‐Aboriginal Australians. BMC Health Serv Res 2018; 18: 776.
Rodger JC, Supramaniam R, Gibberd AJ, et al. Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia. BJU Int 2015; 115: 16‐23.
Jessop S, Ruhayel S, Sutton R, et al. Are outcomes for childhood leukaemia in Australia influenced by geographical remoteness and Indigenous race? Pediatr Blood Cancer 2021; 68: e28945.
Cunningham J, Garvey G. Are there systematic barriers to participation in cancer treatment trials by Aboriginal and Torres Strait Islander cancer patients in Australia? Aust N Z J Public Health 2021; 45: 39‐45.
Anderson K, Diaz A, Parikh DR, Garvey G. Accessibility of cancer treatment services for Indigenous Australians in the Northern Territory: perspectives of patients and care providers. BMC Health Serv Res 2021; 21: 95.
Jessop S, Hill S, Bicanin K, et al. Aboriginal children with cancer: the patient and healthcare worker perspective. Pediatr Blood Cancer 2024; 71: e30747.
Whop LJ, Valery PC, Beesley VL, et al. Navigating the cancer journey: a review of patient navigator programs for Indigenous cancer patients. Asia Pac J Clin Oncol 2012; 8: 89‐96.
Corbett CM, Somers TJ, Nuñez CM, et al. Evolution of a longitudinal, multidisciplinary, and scalable patient navigation matrix model. Cancer Med 2020; 9: 3202‐3210.
Reilly R, Micklem J, Yerrell P, et al. Aboriginal experiences of cancer and care coordination: lessons from the Cancer Data and Aboriginal Disparities (CanDAD) narratives. Health Expect 2018; 21: 927‐936.
National Aboriginal Community Controlled Health Organisation. NACCHO Aboriginal and Torres Strait Islander Cancer Plan. Canberra: NACCHO, 2023. https://www.naccho.org.au/cancer/ (viewed Jan 2024).
Cancer Australia. Australian Cancer Plan. Sydney: Cancer Australia, 2023. https://www.australiancancerplan.gov.au/welcome (viewed Dec 2023).
Victorian Aboriginal Community Controlled Health Organisation. The Beautiful Shawl: implementation model. Melbourne: VACCHO, 2022. https://clara.breastscreen.org.au/intranet/documents/11/3800/The_Beautiful_Shawl_Implementation_Model_Apr2022.pdf (viewed Dec 2023).
Victorian Aboriginal Community Controlled Health Organisation. Victorian Aboriginal Cancer Journey Strategy. Melbourne: VACCHO, 2023. https://www.vaccho.org.au/wp‐content/uploads/2023/05/VACCHO_Victorian‐Aboriginal‐Cancer‐Journey‐Strategy‐2023‐2028_Web.pdf (viewed Dec 2023).
Dasgupta P, Condon JR, Whop LJ, et al. Access to aboriginal community‐controlled primary health organizations can explain some of the higher Pap test participation among Aboriginal and Torres Strait Islander women in North Queensland, Australia. Front Oncol 2021; 11: 725145.
Menzies School of Health Research. National Indigenous bowel screening pilot — final report, October 2020. Darwin: Menzies School of Health Research, 2020. https://www.health.gov.au/sites/default/files/documents/2021/06/final‐report‐on‐the‐national‐indigenous‐bowel‐screening‐pilot.pdf (viewed Dec 2023).
National Aboriginal Community Controlled Health Organisation. Annual report 2022–2023. Canberra: NACCHO, 2023. https://www.naccho.org.au/publications‐resources/ (viewed Jan 2024).
Marmion D, Obata K, Troy J. Community, identity, wellbeing: the report of the Second National Indigenous Languages Survey. Canberra: Australian Institute Aboriginal and Torres Strait Islander Studies, 2014. https://aiatsis.gov.au/sites/default/files/2020‐09/2014‐report‐2nd‐national‐indigenous‐languages‐survey.pdf (viewed Jan 2024).
Silcocks M, Farlow A, Hermes A, et al. Indigenous Australian genomes show deep structure and rich novel variation. Nature 2023; 624: 593‐601.
Reis ALM, Rapadas M, Hammond JM, et al. The landscape of genomic structural variation in Indigenous Australians. Nature 2023; 624: 602‐610.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405‐424.
Samarasinghe SR, Hoy W, Jadhao S, et al. The pharmacogenomic landscape of an Indigenous Australian population. Front Pharmacol 2023; 14: 1180640.
Goetz MP, Sangkuhl K, Guchelaar HJ, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and tamoxifen therapy. Clin Pharmacol Ther 2018; 103: 770‐777.
Schneider VA, Graves‐Lindsay T, Howe K, et al. Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly. Genome Res 2017; 27: 849‐864.
Guerrero S, López‐Cortés A, Indacochea A, et al. Analysis of racial/ethnic representation in select basic and applied cancer research studies. Sci Rep 2018; 8: 13978.
Fox K. The illusion of inclusion — the “All of Us” research program and Indigenous peoples’ DNA. N Engl J Med 2020; 383: 411‐413.
Dodson M, Williamson R. Indigenous peoples and the morality of the Human Genome Diversity Project. J Med Ethics 1999; 25: 204‐248.
Ministry of Health. New Zealand Cancer Action Plan 2019–2029 — Te Mahere mō te Mate Pukupuku o Aotearoa 2019–2029. Wellington: Ministry of Health, 2020. https://www.health.govt.nz/publication/new‐zealand‐cancer‐action‐plan‐2019‐2029 (viewed Dec 2023).
Cancer Care Ontario, Ontario Health. First Nations, Inuit, Métis and Urban Indigenous Cancer Strategy 2019–2023. Ontario: Ontario Health, 2019. https://www.cancercareontario.ca/en/cancer‐care‐ontario/programs/aboriginal‐programs/indigenous‐cancer‐strategy (viewed Jan 2024).
Joint Commission on Closing the Gap. National Agreement on Closing the Gap. Canberra: Joint Commission on Closing the Gap, 2020. https://www.closingthegap.gov.au/national‐agreement (viewed Jan 2024).
Bouzalmate‐Hajjaj A, Massó Guijarro P, Khan KS, et al. Benefits of participation in clinical trials: an umbrella review. Int J Environ Res Public Health 2022; 19: 15368.
Caron NR, Chongo M, Hudson M, et al. Indigenous genomic databases: pragmatic considerations and cultural contexts. Front Public Health 2020; 8: 111.
Liao WW, Asri M, Ebler J, et al. A draft human pangenome reference. Nature 2023; 617: 312‐324.
National Health and Medical Research Council. An Indigenous Australian reference genome: Indigenous inclusion in the benefits of genomic medicine. Canberra: NHMRC, 2018. https://www.grants.gov.au/Ga/Show/A8935E11‐E7E8‐A9B6‐007A‐4422116C78EA (viewed May 2024).
Ivers R, Jackson B, Levett T, et al. Home to health care to hospital: evaluation of a cancer care team based in Australian Aboriginal primary care. Aust J Rural Health 2019; 27: 88‐92.
United Nations. United Nations Declaration on the Rights of Indigenous Peoples [A/RES/61/295]. New York: UN, 2007. https://www.un.org/development/desa/indigenouspeoples/wp‐content/uploads/sites/19/2018/11/UNDRIP_E_web.pdf (viewed May 2024).
Hudson M, Garrison NA, Sterling R, et al. Rights, interests and expectations: Indigenous perspectives on unrestricted access to genomic data. Nat Rev Genet 2020; 21: 377‐384.
Carroll SR, Garba I, Figueroa‐Rodríguez OL, et al. The CARE Principles for Indigenous data governance. Data Sci J 2020; 19: 43.
National Health and Medical Research Council. Ethical conduct in research with Aboriginal and Torres Strait Islander Peoples and communities. Canberra: NHMRC, 2018. https://www.nhmrc.gov.au/about‐us/resources/ethical‐conduct‐research‐aboriginal‐and‐torres‐strait‐islander‐peoples‐and‐communities (viewed Dec 2023).
Morey K, Franks C, Pearson O, et al. Research ACCORDing to whom? Developing a South Australian Aboriginal and Torres Strait Islander Health Research Accord. Lowitja Journal 2023; 1: 100003.
Kaladharan S, Vidgen ME, Pearson JV, et al. Ask the people: developing guidelines for genomic research with Aboriginal and Torres Strait Islander peoples. BMJ Glob Health 2021; 6: e007259.
QIMR Berghofer Medical Research Institute. Genomic partnerships: guidelines for genomic research with Aboriginal and Torres Strait Islander peoples of Queensland. Brisbane: QIMR Berghofer Medical Research Institute, 2019. https://www.qimrberghofer.edu.au/wp‐content/uploads/2020/09/2019‐Indigenous‐Health‐Genomics‐Guide‐v9‐WEB.pdf (viewed Jan 2024).
فهرسة مساهمة: Keywords: Cancer; Indigenous health
تواريخ الأحداث: Date Created: 20240701 Date Completed: 20240701 Latest Revision: 20240701
رمز التحديث: 20240701
DOI: 10.5694/mja2.52346
PMID: 38946636
قاعدة البيانات: MEDLINE
الوصف
تدمد:1326-5377
DOI:10.5694/mja2.52346